VDK Nutrition Biotech Co., Ltd. is a newly shaped high-tech enterprise specializing in the research and development, production, and sales of biological health products, which is based on the health section of BLRH Biotech Group. The company is located in the Xinxing Zone, Mancheng, Baoding,Hebei, China covering an area of 70 mu with a total investment of US$41 million. Relying on synthetic biology technology and supported by large-scale industrial fermentation technology, the company has realized subversive innovation and substitution of traditional production technology, and it has become a new benchmark in the health industry. Among the company’s products, the 5- hydroxytryptophan（5-HTP) and melatonin produced through biological fermentation have filled the gaps at home and abroad, and their market shares are both over 70%.
The company’s main business focuses on the bio-manufacturing of natural products. Relying on synthetic biological technology, it produces functional substances of natural products through microbial cell factories, thus solving a series of problems that perplex the production of traditional plant extraction products, such as limited plant producing areas and sources, difficult quality control during plant planting, complex and difficult purification of plant extract components, and serious environmental pollution, etc. The company’s R&D and production mainly comprises 4 modules: firstly, exploring the metabolic pathways, key enzymes and genes of natural products; then, improving the catalytic efficiency and selectivity of enzymes through enzyme evolution and the high-throughput screening; thirdly, reconstructing genetic engineering bacteria to achieve microbial expression of natural products; culturing the constructed genetic engineering bacteria industrially and realizing large-scale biological manufacture of natural products in cell factories. After melatonin was successfully put into production in 2020, the company successfully developed resveratrol and its derivatives in 2021, which have continuously enriched the product series of the company, and many new products are on the R&D pipeline.
Through source innovation and subversive innovation, after the company’s first product, 5- HTP, was put into production in 2019, it quickly opened up its market with its natural quality, ultra-high purity and stable delivery, and its market share reached over 70% in 2021. To continuously meet people’s extensive needs for a healthy life, the company has taken precautions beforehand by starting the construction of the second-phase expansion project. The project covers an area of 90 mu, which will be used for the production and manufacture of the derivatives and downstream series of products with 5-hydroxytryptophan as mother nucleus, so as to build a complete product chain.
The company’s food quality and safety management system based on cGMP and HACCP has passed BRC, FSMA, GFSI, Kosher, and Halal certifications and the certification of quality / environment / occupational safety and health management system, which fully meets the needs of users. Under the fundamental policy of national sustainable development, the company always adheres to the original tenet of “ameliorating the natural environment and raising the level of human health”. All R&D and production products are meant to apply green and clean production technology, practice replacing old growth drivers with new ones and the transformation of economic development mode nationwide and help to achieve the goals of energy conservation and emission reduction and sustainable development.
VDK Nutrition takes good care of human health.